Perfil
Scott Schaus was the founder of Seaport Diagnostics, Inc., founded in 2014, where the title held was Chief Scientific Officer.
Mr. Schaus is the founder of Virex Health LLC, founded in 2022, holding the title of Chief Technology Officer.
Mr. Schaus is currently Chief Technology Officer at Sorrento Therapeutics, Inc. since 2022.
Formerly, Mr. Schaus was a Professor at Boston University.
Cargos activos de Scott Schaus
| Empresas | Cargo | Inicio |
|---|---|---|
| SORRENTO THERAPEUTICS, INC. | Director Técnico/Científico/I+D | 01/03/2022 |
Virex Health LLC
Virex Health LLC Medical/Nursing ServicesHealth Services Provides health diagnostics services | Fundador | 01/01/2022 |
Antiguos cargos conocidos de Scott Schaus.
| Empresas | Cargo | Fin |
|---|---|---|
Boston University
Boston University Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Seaport Diagnostics, Inc.
Seaport Diagnostics, Inc. Medical/Nursing ServicesHealth Services Operates as a diagnostic center for testing | Fundador | - |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 4 |
|---|---|
Boston University
Boston University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sorrento Therapeutics, Inc.
Sorrento Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical and commercial stage biopharmaceutical company that develops treatments for cancer, infectious disease and pain | Health Technology |
Seaport Diagnostics, Inc.
Seaport Diagnostics, Inc. Medical/Nursing ServicesHealth Services Operates as a diagnostic center for testing | Health Services |
Virex Health LLC
Virex Health LLC Medical/Nursing ServicesHealth Services Provides health diagnostics services | Health Services |
- Bolsa de valores
- Insiders
- Scott Schaus
















